U.S. Building Stock News

NasdaqGS:SSNC
NasdaqGS:SSNCProfessional Services

Assessing SS&C Technologies (SSNC) After Recent Share Price Weakness And DCF Upside Potential

If you are wondering whether SS&C Technologies Holdings is offering fair value at its current price, or if the market is mispricing it, this article walks through the key numbers that matter for you as a shareholder or potential investor. The stock last closed at US$75.29, with a recent 5.5% gain over 7 days sitting against a 12.2% decline year to date and a 14.4% decline over the past year. The 3 year and 5 year returns are 31.4% and 21.6% respectively. These mixed returns sit alongside an...
NasdaqGS:LAUR
NasdaqGS:LAURConsumer Services

How Laureate Education’s Bigger Buyback and 2026 Outlook At Laureate Education (LAUR) Has Changed Its Investment Story

On 19 February 2026, Laureate Education reported fourth-quarter 2025 results showing higher sales and earnings per share than a year earlier, issued first-quarter and full-year 2026 revenue guidance, and disclosed completion of a US$218.89 million buyback under its existing program. On the same day, the company also expanded its capital return plans by increasing its share repurchase authorization to US$400 million, signaling management’s confidence in its financial capacity while it...
NasdaqGS:HNST
NasdaqGS:HNSTPersonal Products

Honest Company (HNST) Valuation Check After Wider Loss Lower Revenue And New US$25m Buyback

Honest Company (HNST) has drawn fresh attention after reporting full year 2025 results that show lower sales and a wider net loss, along with new 2026 guidance and a US$25 million share repurchase program. See our latest analysis for Honest Company. At a share price of US$2.80, recent moves have been mixed, with a strong 7 day share price return of 23.35% and a 30 day share price return of 13.36%. However, a 1 year total shareholder return decline of 48.15% suggests longer term holders have...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Syndax’s Third FDA Win Accelerates Shift To Multi Product Revenues

Syndax Pharmaceuticals secured its third FDA approval within a year, following the launches of Revuforj and Niktimvo. The company is rapidly shifting into a commercial-stage model with revenues now coming from multiple newly approved therapies. Pivotal clinical trials are in progress that could support label expansions and additional indications. Syndax Pharmaceuticals, NasdaqGS:SNDX, is moving from a pure R&D story to an active commercial player, supported by three FDA approved therapies...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Flywire Taps Payments Veteran As CTO To Drive AI First Growth

Flywire appointed Patrick Blanc as Chief Technology Officer as part of a leadership realignment focused on AI driven product development. Blanc brings payments technology experience from senior roles at Ingenico, Visa, and PayPal. David King moved into the role of Chief Product Officer and Co President of Global Education to support Flywire's product and sector focus. For investors tracking NasdaqGS:FLYW, this leadership reshuffle comes with the stock recently closing at $12.31 and showing...
NasdaqGS:RJET
NasdaqGS:RJETAirlines

Assessing Republic Airways (RJET) Valuation After Recent Share Price Momentum

Republic Airways Holdings (RJET) has drawn fresh attention after recent trading, with the stock up 1.7% on the day and double digit gains over the past month and the past 3 months. See our latest analysis for Republic Airways Holdings. With the latest share price at $21.73, a 1 day share price return of 1.7% builds on a 7 day gain of 10.0% and a 30 day share price return of 26.3%. The year to date move of 10.8% suggests momentum has picked up recently compared with earlier in the year. If...
NasdaqGS:SAIL
NasdaqGS:SAILSoftware

Is It Time To Reassess SailPoint (SAIL) After A 41% One Year Share Price Slide

If you are wondering whether SailPoint is starting to look interesting on price, this is a good moment to step back and ask what its current market value really reflects. The stock last closed at US$14.10, with returns of 0.6% decline over 7 days, 10.1% decline over 30 days, 25.6% decline year to date and 41.2% decline over the past year. These moves can change how investors think about both potential upside and risk. Recent news around SailPoint has focused on its role in identity security...
NasdaqGM:AAOI
NasdaqGM:AAOICommunications

Is Applied Optoelectronics (AAOI) Still Sensibly Priced After Its Huge Recent Share Price Surge

If you are wondering whether Applied Optoelectronics is still attractively priced after its big run, this article will help you weigh what you are paying against what you are getting. The stock recently closed at US$84.23, with returns of 63% over 7 days, 93.1% over 30 days, 112.7% year to date and 285.3% over 1 year, while the 3 year return is very large and the 5 year return sits at 947%. Recent headlines have focused on Applied Optoelectronics as a key name in optical networking and data...
NYSE:CHWY
NYSE:CHWYSpecialty Retail

Chewy Names Christopher Deppe CFO As Market Focuses On Execution

Chewy appointed Christopher S. Deppe as its new Chief Financial Officer after an extensive search. Deppe previously served as Head of Corporate and Commercial Finance at Chewy and held senior leadership roles at Amazon. This is Chewy’s first major permanent executive appointment following an interim period in the finance role. For investors watching NYSE:CHWY, a permanent CFO is a key piece of the puzzle. Chewy’s shares recently closed at $27.42, with a 3.7% gain over the past week but...
NasdaqGS:QRVO
NasdaqGS:QRVOSemiconductor

Is It Too Late To Reassess Qorvo (QRVO) After Its Recent Share Price Rebound?

If you are wondering whether Qorvo at around US$82.90 still offers value or is pricing in too much optimism already, you are not alone. The stock has returned 0.8% over the last 7 days and 6.1% over the last 30 days, while the year to date return sits at a 3.9% decline and the 1 year return is 14.0%. This compares to a 19.3% decline over 3 years and a 51.6% decline over 5 years. Recent coverage of Qorvo has focused on its role within the semiconductor sector and how investor expectations are...
NYSE:PBH
NYSE:PBHPharmaceuticals

Assessing Prestige Consumer Healthcare (PBH) Valuation After Mixed Returns And An 11% Intrinsic Value Discount

Recent Share Performance Snapshot Prestige Consumer Healthcare (PBH) has seen mixed share performance recently, with a 1 day return of roughly a 1.3% decline, a flat result over the past week, and gains over the month and past 3 months. Over longer periods the picture is split, with a 13.2% gain year to date and a 14.9% total return over 3 years, set against an 18.2% total return decline over the past year. See our latest analysis for Prestige Consumer Healthcare. At a share price of $69.30,...
NYSE:DK
NYSE:DKOil and Gas

Is It Too Late To Consider Delek US Holdings (DK) After A 146% One Year Surge?

If you are wondering whether Delek US Holdings is still attractively priced after its recent run, this breakdown will help you frame the current share price against what the business might be worth. The stock last closed at US$38.11, with returns of 10.9% over 7 days, 29.1% over 30 days, 28.0% year to date and 146.1% over the past year. These moves naturally raise questions about both upside potential and changing risk. Recent coverage of Delek US Holdings has focused on its position in the...
NasdaqGM:QCRH
NasdaqGM:QCRHBanks

Does QCR Holdings' (QCRH) Higher Dividend Reveal a New Capital Allocation Playbook?

In February 2026, QCR Holdings, Inc. announced that its Board of Directors approved a cash dividend of US$0.10 per share, payable on April 3, 2026, to shareholders of record as of March 19, 2026, raising the quarterly payout from US$0.06 per share. This sizable step-up in the regular dividend highlights management’s emphasis on returning capital to shareholders while signaling confidence in the company’s financial position. Next, we’ll examine how this materially higher quarterly dividend...
NYSE:TIC
NYSE:TICProfessional Services

Assessing TIC Solutions (NYSE:TIC) Valuation After Recent Share Price Pullback And NV5 Integration Deal

TIC Solutions (TIC) has drawn investor attention after recent trading left the stock around $9.47, with declines over the past week and month, and a roughly flat move over the past 3 months. See our latest analysis for TIC Solutions. Those recent share price declines, including the 3.86% 1 day move and 6.24% 30 day share price return, sit within a weaker picture overall, with a 1 year total shareholder return of 23.38%. If TIC Solutions’ recent pullback has you scanning for other ideas, it...
NasdaqGS:ALKT
NasdaqGS:ALKTSoftware

Is Alkami Technology (ALKT) Pricing Look Attractive After A 46% One-Year Share Price Slide

If you are wondering whether Alkami Technology is starting to look interesting at its current share price, this article will walk through what that price actually implies about the company. The stock last closed at US$16.55, with returns of a 2.8% decline over 7 days, a 21.9% decline over 30 days, a 27.1% decline year to date and a 46.4% decline over the past year, while the 3 year return sits at 7.1%. These moves come as investors continue to track company specific developments and the...
NYSE:YUMC
NYSE:YUMCHospitality

Yum China Holdings (YUMC) Valuation After Strong 2025 Results Raised 2026 Outlook And Insider Stock Sale

Yum China Holdings (YUMC) is back in focus after reporting Q4 and full year 2025 results that highlighted revenue and margin gains, followed by raised 2026 growth expectations and a sizable insider stock sale. See our latest analysis for Yum China Holdings. At a share price of US$54.91, Yum China’s recent 30 day share price return of 11.11% and year to date gain of 13.99% suggest momentum has picked up, even though the 3 year and 5 year total shareholder returns of 7.32% and 3.21% declines...
NYSE:CPRI
NYSE:CPRILuxury

Is Capri Holdings (CPRI) Blending CFO and COO Roles to Recast Its Transformation Ambitions?

Capri Holdings has appointed Tyler Reddien as Chief Financial Officer and Chief Operating Officer, effective March 30, 2026, with interim CFO Rajal Mehta returning to his prior role as Michael Kors brand CFO. The consolidation of finance and operations leadership under Reddien, who brings experience from The Body Shop, Natura &Co, Hertz, and United Airlines, could influence how Capri pursues performance improvement and transformation across its global portfolio. Next, we’ll examine how...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

Huntington Bancshares Merger With Cadence Tests Integration And Value Case

Huntington Bancshares has finalized its merger with Cadence Bank, creating a larger regional banking platform. The bank is preparing a major customer account integration that will bring Cadence customers onto Huntington’s systems. The combined bank expands Huntington’s reach in Texas and the Southeast, with operational and customer changes expected as integration progresses. Huntington Bancshares, ticker NasdaqGS:HBAN, is stepping into its next phase as a combined institution after closing...
NYSE:WSM
NYSE:WSMSpecialty Retail

Williams Sonoma’s GreenRow Adds Naturepedic To Support Organic Sleep Valuation Narrative

Naturepedic has entered an exclusive retail partnership with GreenRow, a Williams-Sonoma (NYSE:WSM) brand. The collaboration introduces a dedicated assortment of certified organic sleep products for GreenRow customers. The new Aurora Mattress is debuting as part of the deal, expanding Naturepedic's organic mattress lineup. For Williams-Sonoma, known for premium home and kitchen brands, this move adds more certified organic, healthier sleep options to the GreenRow offering. It aligns with...
NYSE:DOCN
NYSE:DOCNIT

Is It Time To Reconsider DigitalOcean (DOCN) After Recent Share Price Volatility

If you are wondering whether DigitalOcean Holdings is still attractively priced after its recent run, you are not alone. This article will help you weigh what the current share price really reflects. The stock most recently closed at US$56.06, with returns of 1.5% over the last 30 days, 14.5% year to date, and 30.8% over the past year. The last 7 days showed an 11.9% decline that may have changed how some investors see the risk and reward trade off. Recent news coverage has focused on...
NYSE:BVN
NYSE:BVNMetals and Mining

Buenaventura Dividend Policy Rises As San Gabriel Nears Full Contribution

Buenaventura (NYSE:BVN) has approved a higher dividend payout policy, supported by strong operating cash flow. The Board also cleared a higher dividend distribution to shareholders under the new framework. The San Gabriel project is approaching completion, with ramp up reported as close to finished. For you as an investor, the combination of a higher dividend payout policy and a near complete San Gabriel ramp up is a key development for Compañía de Minas Buenaventura, a precious metals...
NYSE:OGE
NYSE:OGEElectric Utilities

Is It Too Late To Consider OGE Energy (OGE) After Its Strong Multi‑Year Share Price Run?

If you are wondering whether OGE Energy is still fairly priced after its recent run, or if the current share price is giving you a margin of safety, this article walks through what the numbers say about value. With the stock at US$49.14 and returns of 3.8% over 7 days, 12.5% over 30 days, 14.6% year to date, 10.3% over 1 year, 56.3% over 3 years and 93.0% over 5 years, many investors are asking whether the current price still makes sense. Recent attention on OGE Energy has focused on how a...
NasdaqGS:LZ
NasdaqGS:LZProfessional Services

Reassessing LegalZoom (LZ) After A 31% One‑Year Share Price Decline

If you are wondering whether LegalZoom.com’s current share price reflects its true worth, you are not alone. This article focuses on what the numbers say about value. The stock last closed at US$7.03, with a 7 day return of 7.2%, but declines of 20.9% over 30 days, 26.7% year to date, and 30.8% over the past year. These moves have put valuation questions front and center for many investors, who are weighing short term swings against the longer term picture. Evergreen coverage like this aims...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

Assessing PTC Therapeutics (PTCT) Valuation After Contrasting Quarterly Loss And Full Year Profit Turnaround

PTC Therapeutics (PTCT) shares are in focus after the company released fourth quarter and full year 2025 results, which combined weaker quarterly figures with a sharp full year swing to positive earnings. See our latest analysis for PTC Therapeutics. At a share price of US$68.19, PTC Therapeutics has recently seen weaker short term share price returns, with a 30 day share price return of 9.72% and a year to date share price return of 11.14%. Its 1 year total shareholder return of 23.4% and 3...